NSN 6505-01-374-5874
Part Details | SUMATRIPTAN SUCCINATE INJECTION
6505-01-374-5874
Alternate Parts: NDC00173044902, NDC00173-0449-02, NDC00173044902, NDC00173-0449-02, NDC00173044902, NDC00173-0449-02, IMITREX INJECTION, IMITREX, NDC00173044902, NDC00173-0449-02, 6505-01-374-5874, 01-374-5874, 6505013745874, 013745874
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | APR 26, 1993 | 01-374-5874 | 49863 ( SUMATRIPTAN SUCCINATE INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-374-5874
Part Number | Cage Code | Manufacturer |
---|---|---|
NDC00173-0449-02 | 1XUY5 | AMERISOURCEBERGEN DRUG CORPORATIONDIV CORPORATE OFFICE |
NDC00173-0449-02 | 0A423 | CARDINAL HEALTH 100 INCDBA BINDLEY WESTERN TENNESSEE DIV |
NDC00173-0449-02 | 34006 | GLAXO WELLCOME INC |
IMITREX INJECTION | 34006 | GLAXO WELLCOME INC |
IMITREX | 34006 | GLAXO WELLCOME INC |
NDC00173-0449-02 | 4LQT5 | VETERANS HEALTH |
Technical Data | NSN 6505-01-374-5874
Characteristic | Specifications |
---|---|
ACTIVE MEDICAMENT MEDICINAL STRENGTH | AU6.000 MILLIGRAMS SUMATRIPTAN SUCCINATE |
PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
TOTAL PRIMARY CONTAINER QUANTITY | 5 |
THERAPEUTIC EQUIVALENT | TO IMITREX BY GLAXO |
PART NAME ASSIGNED BY CONTROLLING AGENCY | SUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML 2ML VIAL 5S |